Concepedia

David Schaer

DS

Statistics

Publications

29

Citations

3.3K

H-Index

20

Active since

1978

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Eli Lilly (United States)

Cornell University

Swim Across America

Kettering University

David Schaer is an author at Memorial Sloan Kettering Cancer Center specializing in cancer immunotherapy, immunology, and oncology.

ORCID

Publications per year

1978–2024

29

Publications

29

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

Miriam Benezra, Oula Peñate Medina, Pat Zanzonico et al. · Journal of Clinical Investigation · 2011 · 640 citations · Full text

, , +17

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

David Schaer, Richard P. Beckmann, Jack Dempsey et al. · Cell Reports · 2018 · 460 citations · Full text

, , +17

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

Rikke Holmgaard, David Schaer, Yanxia Li et al. · Journal for ImmunoTherapy of Cancer · 2018 · 369 citations · Full text

, , +17

Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

Adam D. Cohen, David Schaer, Cailian Liu et al. · PLoS ONE · 2010 · 256 citations · Full text

, , +17

Rational design of anti-GITR-based combination immunotherapy

Roberta Zappasodi, Cynthia A. Sirard, Yanyun Li et al. · Nature Medicine · 2019 · 228 citations · Full text

, , +14

1–5 of 29